Stock comparison
United Therapeutics
UTHR$24.13BHealthcare Market cap, Sector
Zimmer Biomet Holdings
ZBH$16.54BHealthcare Market cap, Sector
Overall winner
United Therapeutics
UTHR 70 ZBH
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
UTHR7wins
0winsZBH
71B
C60
76B
D57
76B
D55
62C
F44
46D
F32
64C
D50
64C
D54
Side-by-side metrics
| Metric | UTHR | ZBH |
|---|---|---|
| Market cap | Winner: $24.13B | $16.54B |
| P/E (TTM) | Winner: 19.2x | 21.4x |
| EV/EBIT | Winner: 15.2x | 17.1x |
| ROIC (TTM) | Winner: 18.81% | 4.98% |
| Gross margin | Winner: 86.58% | 70.03% |
| Net margin | Winner: 40.61% | 9.05% |
| Revenue CAGR 5y | Winner: 17.22% | 4.79% |
| EPS CAGR 5y | Winner: 29.84% | 16.54% |
| Debt / Equity | Winner: - | 0.5x |
| Dividend yield | 0.0% | 1.15% Winner |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
UTHR leads on
- Debt / Equity-vs 0.5x+100%
- Net margin40.61%vs 9.05%+78%
- ROIC (TTM)18.81%vs 4.98%+74%
- Revenue CAGR 5y17.22%vs 4.79%+72%
ZBH leads on
- Dividend yield1.15%vs 0.0%+100%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.